|
Insider Trading: Alexion Pharmaceuticals Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Alexion Pharmaceuticals Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Alexion Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Alexion Pharmaceuticals Inc since 2005.
The reporting company's ticker symbol is ALXN.
The reporting company's CIK number is 899866.
The total value of stock buying since 2005 is $773,498.
The total value of stock sales is $42,146,789.
The total value of stock exercises is $12,499,910.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Alexion Pharmaceuticals Inc (ALXN) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Figure 2. Average prices of insider buys, sales, and option exercises at Alexion Pharmaceuticals Inc (ALXN) in the past 24 months. See table 2 for insider transaction details.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Alexion Pharmaceuticals Inc (ALXN).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-08 | 0 | 0 | 24,221 | 2,226,393 | 19,500 | 1,058,362 |
| 2008-07 | 0 | 0 | 70,097 | 5,808,407 | 69,500 | 1,344,415 |
| 2008-06 | 0 | 0 | 6,500 | 458,687 | 6,500 | 141,440 |
| 2008-05 | 0 | 0 | 87,827 | 6,145,918 | 35,827 | 640,183 |
| 2008-04 | 0 | 0 | 8,590 | 601,300 | 12,000 | 108,000 |
| 2008-03 | 0 | 0 | 1,858 | 106,372 | 0 | 0 |
| 2008-02 | 0 | 0 | 12,590 | 847,245 | 12,000 | 108,000 |
| 2008-01 | 0 | 0 | 2,687 | 185,456 | 0 | 0 |
| 2007-12 | 0 | 0 | 20,590 | 1,536,538 | 24,800 | 622,950 |
| 2007-11 | 0 | 0 | 77,548 | 4,604,137 | 84,727 | 2,910,400 |
| 2007-10 | 0 | 0 | 0 | 0 | 22,000 | 1,736,355 |
| 2007-09 | 0 | 0 | 5,094 | 324,733 | 0 | 0 |
| 2007-08 | 0 | 0 | 500 | 29,492 | 2,000 | 20,760 |
| 2007-07 | 0 | 0 | 29,250 | 1,667,288 | 29,250 | 294,499 |
| 2007-06 | 0 | 0 | 25,000 | 1,212,500 | 60,166 | 921,734 |
| 2007-05 | 5,023 | 236,633 | 196,547 | 9,280,351 | 113,250 | 98,437 |
| 2007-03 | 0 | 0 | 21,665 | 944,066 | 30,000 | 311,400 |
| 2007-01 | 0 | 0 | 9,375 | 380,472 | 9,375 | 98,437 |
| 2006-11 | 0 | 0 | 39,075 | 1,608,504 | 68,400 | 890,118 |
| 2006-10 | 0 | 0 | 20,100 | 760,986 | 30,000 | 311,400 |
| 2006-09 | 0 | 0 | 21,200 | 718,722 | 30,000 | 311,400 |
| 2006-08 | 0 | 0 | 16,580 | 523,928 | 0 | 0 |
| 2006-03 | 0 | 0 | 11,912 | 456,824 | 11,912 | 119,120 |
| 2006-02 | 0 | 0 | 35,000 | 1,129,170 | 35,000 | 352,500 |
| 2006-01 | 0 | 0 | 10,000 | 284,000 | 10,000 | 100,000 |
| 2005-11 | 2,500 | 54,400 | 0 | 0 | 0 | 0 |
| 2005-10 | 18,049 | 482,465 | 0 | 0 | 0 | 0 |
| 2005-06 | 0 | 0 | 13,150 | 305,300 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Alexion Pharmaceuticals Inc (ALXN)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-08-08 | Dubin Thomas I H (SVP and General Counsel) | Sale | 4,721 | 90.47 | 427,108 |
| 2008-08-05 | Parven Alvin S (Director) | Sale | 9,500 | 91.63 | 870,485 |
| 2008-08-05 | Parven Alvin S (Director) | Option Exercise | 9,500 | 82.38 | 782,562 |
| 2008-08-01 | Sinha Vikas (Sr VP and CFO) | Sale | 10,000 | 92.88 | 928,800 |
| 2008-08-01 | Sinha Vikas (Sr VP and CFO) | Option Exercise | 10,000 | 27.58 | 275,800 |
| 2008-07-31 | Waeger Ruedi E (Director) | Sale | 19,500 | 93.63 | 1,825,785 |
| 2008-07-31 | Waeger Ruedi E (Director) | Option Exercise | 19,500 | 20.14 | 392,632 |
| 2008-07-30 | Keiser David W (President & COO) | Sale | 10,000 | 90.00 | 900,000 |
| 2008-07-30 | Keiser David W (President & COO) | Option Exercise | 10,000 | 21.00 | 210,000 |
| 2008-07-25 | Keiser David W (President & COO) | Sale | 20,000 | 80.00 | 1,600,000 |
| 2008-07-25 | Keiser David W (President & COO) | Option Exercise | 20,000 | 19.94 | 398,850 |
| 2008-07-10 | Sinha Vikas (SVP & CFO) | Sale | 159 | 75.75 | 12,044 |
| 2008-07-10 | Squinto Stephen P (EVP & Head of Research & Devel) | Sale | 159 | 75.75 | 12,044 |
| 2008-07-10 | Keiser David W (President & COO) | Sale | 159 | 75.75 | 12,044 |
| 2008-07-10 | Dubin Thomas I H (SVP & General Counsel) | Sale | 120 | 75.75 | 9,090 |
| 2008-07-01 | Keiser David W (President & COO) | Sale | 20,000 | 71.87 | 1,437,400 |
| 2008-07-01 | Keiser David W (President & COO) | Option Exercise | 20,000 | 17.15 | 342,933 |
| 2008-06-04 | Parven Alvin S (Director) | Sale | 6,500 | 70.57 | 458,687 |
| 2008-06-04 | Parven Alvin S (Director) | Option Exercise | 6,500 | 21.76 | 141,440 |
| 2008-05-19 | Squinto Stephen P (EVP & Head of Research & Devel) | Sale | 35,827 | 69.81 | 2,500,993 |
| 2008-05-19 | Squinto Stephen P (EVP & Head of Research & Devel) | Option Exercise | 35,827 | 17.87 | 640,183 |
| 2008-05-14 | Mathis Larry (Director) | Sale | 2,000 | 71.02 | 142,031 |
| 2008-05-01 | Keiser David W (President & COO) | Sale | 50,000 | 70.06 | 3,502,894 |
| 2008-04-23 | Bell Leonard (CEO) | Sale | 8,590 | 70.00 | 601,300 |
| 2008-04-23 | Bell Leonard (CEO) | Option Exercise | 12,000 | 9.00 | 108,000 |
| 2008-03-24 | Sinha Vikas (SVP & Chief Financial Officer) | Sale | 1,025 | 58.23 | 59,685 |
| 2008-03-10 | Squinto Stephen P (EVP & Head of Research) | Sale | 159 | 56.05 | 8,911 |
| 2008-03-10 | Keiser David W (President & COO) | Sale | 159 | 56.05 | 8,911 |
| 2008-03-10 | Dubin Thomas I H (SVP & General Counsel) | Sale | 515 | 56.05 | 28,865 |
| 2008-02-22 | Parven Alvin S (Director) | Sale | 2,000 | 61.35 | 122,700 |
| 2008-02-20 | Norby R Douglas (Director) | Sale | 2,000 | 61.58 | 123,160 |
| 2008-02-12 | Bell Leonard (CEO) | Sale | 8,590 | 70.01 | 601,385 |
| 2008-02-12 | Bell Leonard (CEO) | Option Exercise | 12,000 | 9.00 | 108,000 |
| 2008-01-10 | Sinha Vikas (SVP & Chief Financial Officer) | Sale | 711 | 69.02 | 49,073 |
| 2008-01-10 | Squinto Stephen P (EVP & Head of Research) | Sale | 712 | 69.02 | 49,142 |
| 2008-01-10 | Keiser David W (President & COO) | Sale | 709 | 69.02 | 48,935 |
| 2008-01-10 | Dubin Thomas I H (SVP & General Counsel) | Sale | 555 | 69.02 | 38,306 |
| 2007-12-17 | Bell Leonard (CEO) | Sale | 8,090 | 73.99 | 598,592 |
| 2007-12-17 | Bell Leonard (CEO) | Option Exercise | 12,300 | 41.50 | 510,450 |
| 2007-12-13 | Keiser David W (President & COO) | Sale | 12,500 | 75.04 | 937,946 |
| 2007-12-13 | Keiser David W (President & COO) | Option Exercise | 12,500 | 9.00 | 112,500 |
| 2007-11-29 | Dubin Thomas I H (SVP & General Counsel) | Sale | 1,650 | 75.20 | 124,080 |
| 2007-11-28 | Dubin Thomas I H (SVP & General Counsel) | Sale | 20,000 | 14.20 | 284,100 |
| 2007-11-28 | Dubin Thomas I H (SVP & General Counsel) | Option Exercise | 20,000 | 74.25 | 1,483,969 |
| 2007-11-15 | Bell Leonard (CEO) | Sale | 8,400 | 73.34 | 616,049 |
| 2007-11-15 | Bell Leonard (CEO) | Option Exercise | 12,000 | 9.00 | 108,000 |
| 2007-11-05 | Squinto Stephen P (EVP & Head of Research) | Sale | 34,998 | 75.03 | 2,625,899 |
| 2007-11-05 | Squinto Stephen P (EVP & Head of Research) | Option Exercise | 33,465 | 21.00 | 702,765 |
| 2007-11-01 | Keiser David W (President & COO) | Sale | 12,500 | 76.32 | 954,009 |
| 2007-11-01 | Keiser David W (President & COO) | Option Exercise | 12,500 | 9.00 | 112,500 |
| 2007-10-29 | Parven Alvin S (Director) | Option Exercise | 22,000 | 78.93 | 1,736,355 |
| 2007-09-24 | Sinha Vikas (SVP & Chief Financial Officer) | Sale | 4,162 | 63.40 | 263,883 |
| 2007-09-10 | Squinto Stephen P (EVP & Head of Research) | Sale | 209 | 65.31 | 13,649 |
| 2007-09-10 | Keiser David W (President & COO) | Sale | 209 | 65.22 | 13,632 |
| 2007-09-10 | Dubin Thomas I H (SVP & General Counsel) | Sale | 514 | 65.31 | 33,569 |
| 2007-08-21 | Madri Joseph A (Director) | Sale | 500 | 58.98 | 29,492 |
| 2007-08-21 | Madri Joseph A (Director) | Option Exercise | 2,000 | 10.38 | 20,760 |
| 2007-07-30 | Keiser David W (President & COO) | Sale | 4,250 | 58.77 | 249,788 |
| 2007-07-30 | Keiser David W (President & COO) | Option Exercise | 4,250 | 10.50 | 44,625 |
| 2007-07-25 | Squinto Stephen P (EVP & Head of Research) | Sale | 25,000 | 56.70 | 1,417,500 |
| 2007-07-25 | Squinto Stephen P (EVP & Head of Research) | Option Exercise | 25,000 | 10.00 | 249,874 |
| 2007-06-11 | Link Max (Director) | Option Exercise | 35,166 | 19.64 | 690,484 |
| 2007-06-01 | Squinto Stephen P (EVP & Head of Research) | Sale | 25,000 | 48.50 | 1,212,500 |
| 2007-06-01 | Squinto Stephen P (EVP & Head of Research) | Option Exercise | 25,000 | 9.25 | 231,250 |
| 2007-05-29 | Mojcik Christopher F (SVP Clinical Development) | Purchase | 5,023 | 47.11 | 236,633 |
| 2007-05-29 | Mojcik Christopher F (SVP Clinical Development) | Sale | 98,852 | 47.34 | 4,671,560 |
| 2007-05-29 | Mojcik Christopher F (SVP Clinical Development) | Option Exercise | 103,875 | .00 | 0 |
| 2007-05-08 | Keiser David W (President & COO) | Sale | 9,375 | 47.00 | 440,625 |
| 2007-05-08 | Keiser David W (President & COO) | Option Exercise | 9,375 | 10.50 | 98,437 |
| 2007-03-26 | Bell Leonard (CEO) | Sale | 19,580 | 44.26 | 866,610 |
| 2007-03-26 | Bell Leonard (CEO) | Option Exercise | 30,000 | 10.38 | 311,400 |
| 2007-03-12 | Squinto Stephen P (EVP & Head of Research) | Sale | 758 | 37.15 | 28,159 |
| 2007-03-12 | Mojcik Christopher F (SVP Clinical Development) | Sale | 569 | 37.15 | 21,138 |
| 2007-03-12 | Dubin Thomas I H (SVP & General Counsel) | Sale | 758 | 37.15 | 28,159 |
| 2007-01-03 | Keiser David W (President & COO) | Sale | 9,375 | 40.58 | 380,472 |
| 2007-01-03 | Keiser David W (President & COO) | Option Exercise | 9,375 | 10.50 | 98,437 |
| 2006-11-22 | Keiser David W (President & COO) | Option Exercise | 2,000 | 10.50 | 21,000 |
| 2006-11-14 | Bell Leonard (Chief Executive Officer) | Sale | 19,350 | 42.32 | 818,913 |
| 2006-11-14 | Bell Leonard (Chief Executive Officer) | Option Exercise | 30,000 | 10.38 | 311,400 |
| 2006-11-09 | Bell Leonard (Chief Executive Officer) | Sale | 19,725 | 40.03 | 789,591 |
| 2006-11-09 | Bell Leonard (Chief Executive Officer) | Option Exercise | 30,000 | 10.38 | 311,400 |
| 2006-11-03 | Parven Alvin S (Director) | Option Exercise | 6,400 | 38.49 | 246,318 |
| 2006-10-16 | Bell Leonard (Chief Executive Officer) | Sale | 20,100 | 37.86 | 760,986 |
| 2006-10-16 | Bell Leonard (Chief Executive Officer) | Option Exercise | 30,000 | 10.38 | 311,400 |
| 2006-09-15 | Bell Leonard (Chief Executive Officer) | Sale | 21,200 | 33.90 | 718,722 |
| 2006-09-15 | Bell Leonard (Chief Executive Officer) | Option Exercise | 30,000 | 10.38 | 311,400 |
| 2006-08-10 | Link Max (Director) | Sale | 16,580 | 31.60 | 523,928 |
| 2006-03-10 | Keiser David W (President & COO) | Sale | 3,005 | 38.35 | 115,241 |
| 2006-03-10 | Keiser David W (President & COO) | Option Exercise | 3,005 | 10.00 | 30,050 |
| 2006-03-10 | Bell Leonard (Chief Executive Officer) | Sale | 8,907 | 38.35 | 341,583 |
| 2006-03-10 | Bell Leonard (Chief Executive Officer) | Option Exercise | 8,907 | 10.00 | 89,070 |
| 2006-02-15 | Squinto Stephen P (EVP & Head of Research) | Sale | 5,000 | 35.05 | 175,250 |
| 2006-02-15 | Squinto Stephen P (EVP & Head of Research) | Option Exercise | 5,000 | 10.50 | 52,500 |
| 2006-02-15 | Bell Leonard (Chief Executive Officer) | Sale | 10,000 | 35.01 | 350,100 |
| 2006-02-15 | Bell Leonard (Chief Executive Officer) | Option Exercise | 10,000 | 10.00 | 100,000 |
| 2006-02-01 | Keiser David W (President & COO) | Sale | 20,000 | 30.19 | 603,820 |
| 2006-02-01 | Keiser David W (President & COO) | Option Exercise | 20,000 | 10.00 | 200,000 |
| 2006-01-30 | Bell Leonard (Chief Executive Officer) | Sale | 10,000 | 28.40 | 284,000 |
| 2006-01-30 | Bell Leonard (Chief Executive Officer) | Option Exercise | 10,000 | 10.00 | 100,000 |
| 2005-11-01 | Link Max (Director) | Purchase | 2,500 | 21.76 | 54,400 |
| 2005-10-13 | Parven Alvin S (Director) | Purchase | 1,049 | 26.74 | 28,050 |
| 2005-10-10 | Mathis Larry (Director) | Purchase | 1,000 | 26.26 | 26,255 |
| 2005-10-10 | Link Max (Director) | Purchase | 15,000 | 26.78 | 401,640 |
| 2005-10-07 | Mathis Larry (Director) | Purchase | 1,000 | 26.52 | 26,520 |
| 2005-06-27 | Boess Carsten (Other) | Sale | 11,250 | 23.38 | 263,025 |
| 2005-06-15 | Bowdish Katherine S (Senior Vice Presiden) | Sale | 0 | 21.57 | 0 |
| 2005-06-08 | Rollins Scott A (Proj. Man.) | Sale | 1,900 | 22.25 | 42,275 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Alexion Pharmaceuticals Inc (symbol ALXN,
CIK number 899866) see
the Securities and Exchange Commission (SEC) website.
|
|
